Irinotecan Accord 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung
7680667660019
CH-66766
Konzentrat
Associated product:
IRINOTECAN Accord 40 mg/2ml flac 2 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
90.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 57.25
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2018
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66766
- Drug name
- Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01CE02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 24/09/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- IRINOTECAN Accord 40 mg/2ml flac 2 ml
- Description (DE)
- IRINOTECAN Accord 40 mg/2ml Durchstf 2 ml
- Market launch
- 24/09/2018
- Narcotic (BTM)
- No
Original drug
Campto, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680534700459
CHF 64.40